CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3

SIMPLE SUMMARY: Breast cancer is a heterogeneous disease and treatment needs to be adapted to individual tumors. Two thirds of breast tumors may benefit from treatment with drugs targeting a specific protein, the estrogen receptor alpha, a regulator of gene expression activated by female sex hormone...

Descripción completa

Detalles Bibliográficos
Autores principales: Porras, Lucas, Gorse, Faustine, Thiombane, Ndeye Khady, Gaboury, Louis, Mader, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657334/
https://www.ncbi.nlm.nih.gov/pubmed/36358871
http://dx.doi.org/10.3390/cancers14215453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657334/
https://www.ncbi.nlm.nih.gov/pubmed/36358871
http://dx.doi.org/10.3390/cancers14215453

Ejemplares similares